News & Trends - MedTech & Diagnostics
Is the NSW healthcare investment a genuine lifeline or just political posturing?

MedTech & Diagnostics News: The New South Wales (NSW) Government has unveiled a $3 billion investment dedicated to enhancing healthcare infrastructure in greater Western Sydney, marking one of the most substantial investments in recent memory.
The highlights of this announcement include the rebuilding of Bankstown-Lidcombe Hospital on a new site, the establishment of a brand-new hospital in Rouse Hill — the first adult public hospital to be built in Western Sydney in over four decades — and investments exceeding hundreds of millions of dollars in upgrading Fairfield and Canterbury Hospitals.
This hefty investment comes on the heels of alarming data from the Bureau of Health Information (BHI), which reveals that nearly 53,000 patients sought emergency care across the Western Sydney Local Health District during the April to June quarter of 2023. Shockingly, this data exposes the agonisingly long wait times faced by patients, with a mere 42% commencing their treatment as scheduled.
Michael Bonning, President of the Australian Medical Association (NSW) and Chief Medical Officer, remarked, “The Australian Medical Association (NSW) has long stressed the need to focus on improving community access to healthcare. The residents of Western Sydney deserve the Chris Minns government’s $3 billion commitment for new and improved hospital facilities at Rouse Hill, Mt Druitt, Fairfield, Bankstown-Lidcombe, Canterbury and Blacktown. This needs to be matched with medical staffing. A hospital bed needs a well-trained team to look after you.”
NSW Premier Chris Minns asserted, “We were elected with a clear mandate to rebuild essential services and invest in our frontline workers. Our healthcare system has been under incredible pressure in recent years, exacerbated by chronic underinvestment from the former government. The thousands of people moving into these growth areas every year deserve world-class healthcare – a commitment my government will steadfastly uphold.”
Opposition Leader Mark Speakman decried some aspects of the plan as mere re-announcements of the previous government rather than innovative initiatives. Shadow Treasurer Damien Tudehope echoed these sentiments, highlighting that “what we are seeing from the government is really an endorsement of the health priorities of the previous government.”
Minister for Western Sydney Prue Car lauded the historic investment, emphasising Western Sydney’s vital role in the state’s growth and the necessity for a proportional investment in services. She stated, “After many years of false promises, this historic level of investment by the Minns Labor Government delivers what the community has been crying out for.”
However, Associate Professor Viraj Kariyawasam, Consultant Gastroenterologist and Hepatologist, stated “There is a lot more to be done. I have been part of a hospital development that delivered state-of-the-art infrastructure that was not appropriately matched with staffing and other resources. We need to get it right this time around.”
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - MedTech & Diagnostics

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms
Hospitals shouldn’t be forced to grovel to private health insurers to secure funding for essential, lifesaving medical devices. But thanks […]
MoreNews & Trends - Pharmaceuticals

Oncologists pioneer liquid biopsy-guided treatment in lung cancer
Lung cancer is Australia’s leading cause of cancer deaths. Local experts are set to lead a new frontier in personalised […]
MoreMedical and Science

The high cost of record low research funding
Australia has delivered some of the world’s most transformative health and medical breakthroughs – the cochlear implant, the HPV vaccine, […]
MoreNews & Trends - Pharmaceuticals

UCB secures dermatology indication with first dual IL-17A/F inhibitor
UCB’s IL-17A and IL-17F inhibitor has been added to the Australian Register of Therapeutic Goods (ARTG) for adults with moderate […]
More